Peggy Scherle

Insider Reports History

Location
Wilmington, DE
Signature
/s/ Bryant D. Lim, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peggy Scherle:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc Chief Scientific Officer Employee Stock Option (right to buy) 230,000 04 Feb 2026 Direct

Insider Reports Filed by Peggy Scherle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRLD Prelude Therapeutics Inc 04 Feb 2026 1 $0 4 Chief Scientific Officer 05 Feb 2026, 16:12
PRLD Prelude Therapeutics Inc 04 Feb 2025 1 $0 4 Chief Scientific Officer 05 Feb 2025, 16:32
PRLD Prelude Therapeutics Inc 01 Mar 2024 1 $0 4 Chief Scientific Officer 04 Mar 2024, 18:07
PRLD Prelude Therapeutics Inc 07 Feb 2023 1 $0 4 Chief Scientific Officer 09 Feb 2023, 15:08
PRLD Prelude Therapeutics Inc 15 Feb 2022 1 $0 4 Chief Scientific Officer 17 Feb 2022, 18:12
PRLD Prelude Therapeutics Inc 26 Aug 2021 8 -$264,756 4 Chief Scientific Officer 30 Aug 2021, 17:16
PRLD Prelude Therapeutics Inc 13 Aug 2021 5 -$76,636 4 Chief Scientific Officer 17 Aug 2021, 16:44
PRLD Prelude Therapeutics Inc 27 Jul 2021 4 -$680,780 4 Chief Scientific Officer 29 Jul 2021, 19:27
PRLD Prelude Therapeutics Inc 20 Jul 2021 1 $0 4 Chief Scientific Officer 22 Jul 2021, 18:17
PRLD Prelude Therapeutics Inc 07 May 2021 5 -$393,892 4 Chief Scientific Officer 11 May 2021, 18:46